Which of the following is the treatment for Burning Mouth Syndrome (BMS)?

Correct answer: B. Nortriptyline (tricyclic antidepressant)

• A. INCORRECT — Benzocaine is a topical anesthetic without therapeutic benefit for the chronic neuropathic pain of BMS.
• B. CORRECT — Nortriptyline (a tricyclic antidepressant) is used for chronic neuropathic pain management in BMS. TCAs modulate central pain processing pathways. Other evidence-based treatments include clonazepam (topical), capsaicin, and alpha-lipoic acid.
• C. INCORRECT — Clonazepam topical (swish and spit) is also an evidence-based option for BMS, but nortriptyline (systemic TCA) is the more classic INBDE answer. Both are valid; source notes both.
• D. INCORRECT — Topical lidocaine provides temporary anesthetic relief but is not a long-term treatment for BMS and does not address the neuropathic mechanism.